In vitro investigation of elevated hemolysis susceptibility in neonatal blood

In vitro investigation of elevated hemolysis susceptibility in neonatal blood

IntroductionHemolysis is a relevant complication and is responsible for morbidity and mortality of neonatal extracorporeal membrane oxygenation (ECMO) therapy. For novel therapies like artificial placenta, hemolysis could also lead to complications or therapy failure, especially since the targeted p...

Full description

Saved in:
Bibliographic Details
Main Authors: Jan Heyer, Stella Volmering, Camila Hoyos-Banchon, Sarah Koc, Lydia Jeremiah, Ulrich Steinseifer, Thorsten Orlikowsky, Sebastian V. Jansen, Johanna C. Clauser, Mark Schoberer
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Pediatrics
Subjects:
preterm infants
artificial placenta
neonatal blood hemolysis
neonatal ECMO
porcine vs. neonatal blood
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2025.1616084/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fped.2025.1616084/full

Similar Items